APC-dependent suppression of colon carcinogenesis by PPARgamma
about
The Role of PPARs in CancerAdvances in understanding the regulation of apoptosis and mitosis by peroxisome-proliferator activated receptors in pre-clinical models: relevance for human health and diseaseSuppression of colitis-related mouse colon carcinogenesis by a COX-2 inhibitor and PPAR ligandsEmerging role of the β-catenin-PPARγ axis in the pathogenesis of colorectal cancerActivation of PPARγ in myeloid cells promotes lung cancer progression and metastasisTherapeutic potential of peroxisome proliferator-activated receptors in chronic inflammation and colorectal cancer.Alzheimer Disease: Crosstalk between the Canonical Wnt/Beta-Catenin Pathway and PPARs Alpha and GammaThe non-genomic crosstalk between PPAR-gamma ligands and ERK1/2 in cancer cell linesCyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin miceHic-5 regulates an epithelial program mediated by PPARgammaMouse models of human familial cancer syndromes.Genome-wide analysis of long noncoding RNA and mRNA co-expression profile in intrahepatic cholangiocarcinoma tissue by RNA sequencing.The Wnt/beta-catenin signaling pathway targets PPARgamma activity in colon cancer cellsPeroxisome proliferator-activated receptor δ confers resistance to peroxisome proliferator-activated receptor γ-induced apoptosis in colorectal cancer cells.Potential role of microsomal prostaglandin E synthase-1 in tumorigenesis.Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activityAbsence of the steroid receptor coactivator-3 induces B-cell lymphoma.Peroxisome proliferator activated receptor gamma in colonic epithelial cells protects against experimental inflammatory bowel diseaseIntestinal tumor suppression in ApcMin/+ mice by prostaglandin D2 receptor PTGDRPPARgamma activation by thiazolidinediones (TZDs) may modulate breast carcinoma outcome: the importance of interplay with TGFbeta signalling.Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality.Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat.MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cellsPPARγ contributes to PKM2 and HK2 expression in fatty liverReview article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer.The effect of body weight on altered expression of nuclear receptors and cyclooxygenase-2 in human colorectal cancers.PPARgamma in human and mouse physiologyAngiogenesis, immune system and growth factors: new targets in colorectal cancer therapy.Thyroid hormone receptors regulate adipogenesis and carcinogenesis via crosstalk signaling with peroxisome proliferator-activated receptors.The toxicology of ligands for peroxisome proliferator-activated receptors (PPAR).Gene-gene, gene-environment & multiple interactions in colorectal cancer.The potential of antidiabetic thiazolidinediones for anticancer therapy.Review article: mode of action and delivery of 5-aminosalicylic acid - new evidence.PPAR γ Networks in Cell Signaling: Update and Impact of Cyclic Phosphatidic Acid.Peroxisome proliferator-activated receptors and progression of colorectal cancer.PPARgamma and PPARdelta as Modulators of Neoplasia and Cell FateNuclear control of the inflammatory response in mammals by peroxisome proliferator-activated receptorsPPARgamma and MEK Interactions in CancerMacrophages, PPARs, and Cancer.
P2860
Q21342955-5D438467-AA1F-4883-939D-E4E380EF243BQ24803926-60F8AF75-28A0-4B9F-BBDF-497117C3578EQ24810709-092ADC90-3805-4B08-961D-C2A29939C046Q26829126-E77B6948-D50D-4741-BB75-936B7F0292DCQ27311601-D8E783FC-736D-413F-8955-F994C49B9AF6Q27687166-7A613876-9E9F-4B90-8DAC-FF3D4FA049D1Q28075617-35D3920A-FAF0-436E-9341-C3E17F028A06Q28238709-08726C27-FF11-4544-B935-6BA9A670F4DFQ28510765-60AFCD70-08E3-4863-A974-674857F0388CQ28586821-45F1B359-9513-4C98-A202-3CE293B970B2Q33204054-AA13A504-5B88-4BE6-B580-E782EE51BC9FQ33688755-270C2D3D-2AD5-49CD-8A6C-22961F27E88AQ33817896-1ABF7F41-3B5A-4A5B-BA0B-315BCC0607F0Q33991703-322DEF8F-76F5-40BA-96DC-1E99AA3E806DQ34182494-E853B37C-75F0-4BD5-99AE-3B268D9D95EBQ34380511-F5434989-1C79-4390-A1DC-85358BD26049Q34524549-4462574A-85BB-4503-86F4-3803492B5B3AQ34676664-1191472B-DD80-4C05-A2C1-2212F046A1AAQ34804346-D0018A95-D65D-47C8-9F23-BD589EA983C2Q35000531-B99484A5-5B91-4F2A-95C8-7E97344EA6EBQ35458969-9FECEA65-30D6-4809-990E-3C63D563C600Q35629015-15C1B38F-881F-4A02-9A44-67595FA011F9Q35695041-31A17040-4167-4CC3-9AD8-61AA3288DD47Q35791401-48633D16-B5F4-47E7-95AE-181388A0A1EBQ35801521-3D19BC58-ECB6-4032-AA5E-E24AFD488968Q36041152-236B5807-EB6A-448C-9817-07EFC1803FA2Q36059703-92E0D505-7654-4D09-A69F-0165CAA6ECF4Q36063081-398D66A6-0B6B-4B33-A02C-9D6709865659Q36235571-2692C03D-0304-4259-A17C-6E2ABAE86FB9Q36297073-63B8393D-F5DD-4B7E-8F8C-13DF2745183EQ36328530-45FD9DA1-B9D1-4E84-90B0-508901D01904Q36475800-CD54DACB-0750-458F-88BF-F7EBDC472047Q36568732-14EBD823-AFB3-4CC8-95FD-F6BFC3858058Q36580628-F9F3CFAE-2871-42D4-B12A-E2A69DE4B4C0Q36637912-EB3F7F88-314A-4986-849D-59648D72FBB8Q36710291-60069DBA-E5F3-4B79-8360-87E1EEB39B9BQ36724712-F7668C28-FCED-4BC2-906C-FF110DA595FDQ36733873-5BC68AD8-10EC-445A-A53B-64E5183F2B1AQ36737285-32BE097D-48C6-48B8-A4B2-B87320139278Q36743885-9D810900-992B-4293-A142-C8B8E9538B0E
P2860
APC-dependent suppression of colon carcinogenesis by PPARgamma
description
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 2002
@ast
im Oktober 2002 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2002/10/15)
@sk
vědecký článek publikovaný v roce 2002
@cs
wetenschappelijk artikel (gepubliceerd op 2002/10/15)
@nl
наукова стаття, опублікована в жовтні 2002
@uk
name
APC-dependent suppression of colon carcinogenesis by PPARgamma
@ast
APC-dependent suppression of colon carcinogenesis by PPARgamma
@en
APC-dependent suppression of colon carcinogenesis by PPARgamma
@nl
type
label
APC-dependent suppression of colon carcinogenesis by PPARgamma
@ast
APC-dependent suppression of colon carcinogenesis by PPARgamma
@en
APC-dependent suppression of colon carcinogenesis by PPARgamma
@nl
prefLabel
APC-dependent suppression of colon carcinogenesis by PPARgamma
@ast
APC-dependent suppression of colon carcinogenesis by PPARgamma
@en
APC-dependent suppression of colon carcinogenesis by PPARgamma
@nl
P2093
P2860
P3181
P356
P1476
APC-dependent suppression of colon carcinogenesis by PPARgamma
@en
P2093
Charis Eng
Daniel W. Rosenberg
Elisabetta Mueller
Frank J. Gonzalez
Geoffrey D. Girnun
Pasha Sarraf
Prashant Nambiar
Raju Kucherlapati
Roderick T. Bronson
Stavit Drori
P2860
P304
13771–13776
P3181
P356
10.1073/PNAS.162480299
P407
P577
2002-10-15T00:00:00Z